covid-19
United in the Fight Against COVID-19
Mobilizing Support for Those We Serve
UnitedHealth Group is leveraging its clinical knowledge and expertise to assist those we serve, providing more than $100 million in support to make a meaningful difference in the fight against COVID-19. From the outset, our singular priority has remained clear: the health, safety and support of the people and communities we serve – including our dedicated team of 330,000 people and the heroic members of the health care workforce – and the reliability and sustainability of health care delivery systems.
We are responding to the coronavirus crisis in India by funding the procurement of more than 2,500 oxygen concentrators to help address the country’s shortage of critical medical equipment essential for treating severe COVID-19 infections.
We have taken action to ensure easy access to affordable care and streamline processes for administering health care for members, health care providers, customers, employers and consumers.
We are providing assistance to our most vulnerable populations, including older adults, individuals who are uninsured, and those experiencing homelessness and food insecurity in hard hit communities in the United States and around the world.
We are collaborating with national organizations to provide resources to meet the clinical, emotional and mental health needs of frontline workers; and we are responding to the strain on liquidity many provider practices are experiencing as a result of the pandemic.
Advancing Breakthrough Innovation
We are leveraging our clinical knowledge, expertise and resources to help develop and advance innovations to fight COVID-19 – actively working with partners on new treatments, testing procedures and lifesaving equipment.
Caring for Team Members and Their Families
We have taken steps to ensure the safety of our 325,000 team members and their families, providing them with resources and support as they continue to serve the members, patients and customers who depend on us.
COVID-19 News
-
StoryAntibody Research & Treatment: How We’re Fighting COVID-19To help improve access to treatment and better understand monoclonal antibodies, UnitedHealth Group and its research unit, OptumLabs, are taking a multifaceted approach toward this promising form of therapy.StoryPartnering to Advance COVID-19 TreatmentUnitedHealth Group is partnering with Eli Lilly to study its new monoclonal antibody treatment, bamlanivimab, for non-hospitalized people recently diagnosed with COVID-19.StoryCollaborating to Accelerate COVID-19 Vaccine ResearchUnitedHealth Group is collaborating with Johnson & Johnson and its Janssen Pharmaceutical Companies to share information about their Phase 3 COVID-19 vaccine candidate trialStoryUnited Health Foundation and AARP Foundation join forces to address social isolation among seniorsThe United Health Foundation and AARP Foundation are collaborating to address social isolation and food insecurity among seniors during the COVID-19 pandemic.StoryExpanding Access to Health Care for Mothers and Babies in Georgia and North CarolinaThe United Health Foundation is helping expand access to health care and improve health outcomes for mothers and babies in Georgia and North Carolina.